Nisoldipine Patent Expiration
Nisoldipine was first introduced by Covis Pharma Gmbh
Nisoldipine Patents
Given below is the list of patents protecting Nisoldipine, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Sular | US5626874 | Controlled release pharmaceutical tablet having lenticular form |
Nov 30, 2014
(Expired) | Covis |
Nisoldipine's Family Patents
Explore Our Curated Drug Screens
Nisoldipine Generic API Manufacturers
Several generic applications have been filed for Nisoldipine. The first generic version for Nisoldipine was by Mylan Pharmaceuticals Inc and was approved on Jul 25, 2008. And the latest generic version is by Amta Labs Ltd and was approved on Apr 10, 2023.
Given below is the list of companies who have filed for Nisoldipine generic, along with the locations of their manufacturing plants worldwide.
1. AMTA
Amta Labs Ltd has filed for 1 generic for Nisoldipine. Given below are the details of the strengths of this generic introduced by Amta.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 8.5MG | tablet, extended release | Discontinued | ORAL | N/A | Apr 10, 2023 |
Manufacturing Plant Locations New
Amta's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Amta as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| United States |
| |||
2. MYLAN
Mylan Pharmaceuticals Inc has filed for 7 different strengths of generic version for Nisoldipine. Given below are the details of the strengths of this generic introduced by Mylan.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 20MG
(reference standard) | tablet, extended release | Prescription | ORAL | N/A | Jul 25, 2008 |
| 30MG | tablet, extended release | Prescription | ORAL | N/A | Jul 25, 2008 |
| 40MG
(reference standard) | tablet, extended release | Prescription | ORAL | N/A | Jul 25, 2008 |
| 8.5MG | tablet, extended release | Prescription | ORAL | AB | Jan 26, 2011 |
| 17MG | tablet, extended release | Prescription | ORAL | AB | Jan 26, 2011 |
| 25.5MG | tablet, extended release | Prescription | ORAL | N/A | Jan 26, 2011 |
| 34MG | tablet, extended release | Prescription | ORAL | AB | Jan 26, 2011 |
Manufacturing Plant Locations New
Mylan's manufacturing plants are situated in 4 countries - United States, India, Canada, Ireland. Given below are the details of these plant locations as well as the firm names of Mylan as present at those locations.
| Country | City | Firm Name | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||
| India |
| |||||||||||||||||
| Canada |
| |||||||||||||||||
| Ireland |
| |||||||||||||||||